Since last year, the listing of the’public offering stock Daeeo’ has been an opportunity for individual investors to expand their investment base. After a large-scale subscription fund was gathered to subscribe to public offering stocks, the subscription fund continued to stay in the stock market, increasing the scale of’Donghak ants’. Even in the subscription to SK Bioscience, the power of’Donghak Ant’ was revealed as it is. As equal distribution and multiple subscriptions became possible, only 2.4 million accounts participated in the public offering, and the subscription fund of 65 trillion won, the largest in history, was gathered. In addition,’Donghak Ant’ is not only playing a supporting role in the stock market in the courtyard, but also making a collective voice on major issues in the stock market. In fact, the introduction of an equal allocation of public stock shares was achieved through the power of Donghak Ants.
SK Bioscience’s share price will be decided by individual investors for the time being. This is because institutional investors (1262 million shares), which are the main supply and demand entities in the stock market, receive the largest amount of public offerings, and their mandatory retention commitment ratio reaches 85%, making it impossible to trade for the time being. At the time of listing, most of the maximum distribution (5.72 million shares) is owned by individuals. Considering that half of the trading volume on the listing date was equivalent to an equally distributed volume such as one or two shares, and all five securities companies with the top selling transactions were subscribed securities companies (NH, Korea, Mirae Asset, Samsung, Hana Financial, etc.). Can be said to have been led by Donghak ants. On the 19th, SK Bioscience ended at 167,500 won, down 0.89% from the previous day due to a failure in’Tasangsang’ (the ceiling was also closed the next day).
Donghak ants’ range of operations is expanding and speeding up, and situations that the existing infrastructure cannot handle are continuing. SK Bioscience’s listing date (18th), the Korea Securities Depository was overloaded because it was unable to meet the demand for a third-party replacement (transferring its stocks to another securities company’s account), and the replacement delivery was delayed. Some brokerage firms’ MTS and HTS connection itself was not possible or delayed. An official from Mirae Asset Daewoo said, “The number of customers who want to trade stocks such as SK Bioscience has temporarily increased, causing a connection error to some MTS and HTS.” Said.
Individual investors who were named’Donghak Ant’ as they invested to protect the stock market in the crash market last year are also playing a supporting role in the stock market this year. From this year to this day, individuals net bought 34,769.4 billion won in the securities market. This is a 93.1% increase from the same period last year (18 trillion won). There are still a lot of investor deposits, which are regarded as stock market funds. According to the Financial Investment Association, the investor’s deposit amounted to 64 trillion 171.2 billion won as of the 18th of this month.
Individuals concentrated on buying growth stocks such as semiconductors and rechargeable batteries in the sideways market where the KOSPI crosses the 2990-3000 line. Until the 19th of this month, individuals bought the most Samsung Electronics in the securities market. In addition, SK Hynix, SK Innovation, and Samsung SDI were among the top net buying companies. SK Bioscience also made a net purchase worth KRW 10.7 billion for both days on the 18th and 19th.
[강봉진 기자 / 신유경 기자]
[ⓒ 매일경제 & mk.co.kr, 무단전재 및 재배포 금지]